Skip to Content
Merck
  • Discovery and optimization of imidazo[1,2-a]pyridine inhibitors of insulin-like growth factor-1 receptor (IGF-1R).

Discovery and optimization of imidazo[1,2-a]pyridine inhibitors of insulin-like growth factor-1 receptor (IGF-1R).

Bioorganic & medicinal chemistry letters (2008-12-23)
Kyle A Emmitte, Brian J Wilson, Erich W Baum, Holly K Emerson, Kevin W Kuntz, Kristen E Nailor, James M Salovich, Stephon C Smith, Mui Cheung, Roseanne M Gerding, Kirk L Stevens, David E Uehling, Robert A Mook, Ganesh S Moorthy, Scott H Dickerson, Anne M Hassell, M Anthony Leesnitzer, Lisa M Shewchuk, Arthur Groy, Jason L Rowand, Kelly Anderson, Charity L Atkins, Jingsong Yang, Peter Sabbatini, Rakesh Kumar
ABSTRACT

The optimization of imidazo[1,2-a]pyridine inhibitors as potent and selective inhibitors of IGF-1R is presented. Further optimization of oral exposure in mice is also discussed. Detailed selectivity, in vitro activity, and in vivo PK profiles of an optimized compound is also highlighted.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Imidazo[1,2-a]pyridine, 99%